fluorescein-5-isothiocyanate has been researched along with 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, JR; Myc, A; Patri, AK | 1 |
1 other study(ies) available for fluorescein-5-isothiocyanate and 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide
| Article | Year |
|---|---|
Dendrimer-based BH3 conjugate that targets human carcinoma cells.
Topics: Apoptosis; Biocompatible Materials; Cell Line, Tumor; Dendrimers; Flow Cytometry; Fluorescein-5-isothiocyanate; Folic Acid; Humans; Jurkat Cells; Macromolecular Substances; Microscopy, Fluorescence; Nanoparticles; Nanostructures; Peptide Fragments; Peptides; Polyamines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tetrazolium Salts | 2007 |